Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

SHE:300122 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,069	2,700	6,341	2,622	4,308	1,437
Cash & Short-Term Investments	3,069	2,700	6,341	2,622	4,308	1,437
Cash Growth	3.27%	-57.41%	141.81%	-39.13%	199.68%	24.98%
Accounts Receivable	14,645	16,273	27,059	20,614	12,868	6,624
Other Receivables	9.33	10.95	7.8	8.39	6.87	9.07
Receivables	14,655	16,284	27,066	20,622	12,874	6,633
Inventory	21,905	22,218	8,986	8,020	7,385	3,406
Prepaid Expenses	5.93	8.11	9.73	-	0.59	5.04
Other Current Assets	40.41	82.61	111.37	148.53	185.63	55.67
Total Current Assets	39,675	41,293	42,514	31,413	24,754	11,537
Property, Plant & Equipment	5,308	5,371	5,120	4,693	3,557	2,387
Long-Term Investments	291	295	295	284.5	239	170
Goodwill	19.28	19.28	19.28	19.28	19.28	19.28
Other Intangible Assets	563.71	300.26	317.68	352.71	342.8	270.53
Long-Term Deferred Tax Assets	956.49	928.5	569.19	186.08	115.34	124.16
Long-Term Deferred Charges	1,347	1,514	1,088	731.97	485.04	402.79
Other Long-Term Assets	179.06	188.44	308.42	322.5	534.91	304.82
Total Assets	48,340	49,910	50,232	38,004	30,047	15,215
Accounts Payable	1,950	5,420	13,142	9,807	9,178	3,084
Accrued Expenses	25.47	866.78	1,673	1,240	1,090	501.54
Short-Term Debt	14,666	11,902	2,635	1,785	568.86	2,874
Current Portion of Long-Term Debt	148.19	83.83	36.41	-	-	-
Current Portion of Leases	-	9.81	10.2	9.81	0.25	-
Current Income Taxes Payable	183.44	80.33	434.59	347.7	933.25	323.7
Current Unearned Revenue	11.63	11.87	11.31	-	-	-
Other Current Liabilities	278.35	67.03	143.86	40.17	99.62	32.88
Total Current Liabilities	17,264	18,441	18,086	13,230	11,871	6,817
Long-Term Debt	279.44	347.59	328.08	210.64	236.41	-
Long-Term Leases	16.71	15.45	25.31	27.76	12.24	-
Long-Term Unearned Revenue	210.7	230.4	228.27	238.34	222.2	115.84
Long-Term Deferred Tax Liabilities	44.32	44.31	57.96	60.77	48.34	29.88
Other Long-Term Liabilities	-	-	-	-	-	4.35
Total Liabilities	17,815	19,079	18,726	13,768	12,390	6,967
Common Stock	2,394	2,394	2,400	1,600	1,600	1,600
Additional Paid-In Capital	-	-	47.96	207.96	207.96	207.96
Retained Earnings	28,132	28,437	29,058	22,428	15,849	6,441
Shareholders' Equity	30,526	30,831	31,506	24,236	17,657	8,249
Total Liabilities & Equity	48,340	49,910	50,232	38,004	30,047	15,215
Total Debt	15,111	12,359	3,035	2,033	817.76	2,874
Net Cash (Debt)	-12,042	-9,658	3,305	588.94	3,490	-1,437
Net Cash Growth	-	-	461.19%	-83.13%	-	-
Net Cash Per Share	-5.03	-4.03	1.38	0.25	1.45	-0.60
Filing Date Shares Outstanding	2,394	2,394	2,400	2,400	2,400	2,400
Total Common Shares Outstanding	2,394	2,394	2,400	2,400	2,400	2,400
Working Capital	22,412	22,852	24,428	18,183	12,883	4,720
Book Value Per Share	12.75	12.88	13.13	10.10	7.36	3.44
Tangible Book Value	29,943	30,511	31,169	23,864	17,295	7,959
Tangible Book Value Per Share	12.51	12.75	12.99	9.94	7.21	3.32
Buildings	-	2,634	2,522	1,705	1,042	1,014
Machinery	-	3,327	2,526	2,064	1,369	904.94
Construction In Progress	-	1,006	1,287	1,836	1,825	906.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.